Typhoid fevers: treatment with lomefloxacin.

Typhoid fevers: treatment with lomefloxacin. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Typhoid fevers: treatment with lomefloxacin. Abstract Text:

S Hafiz,F Habib,N Ahmad,I Haq,R Husain,

Typhoid group of fevers pose a major threat and are a cause of high morbidity and mortality in the tropical countries. Over the last decade there has been a steady increase in the development of multiresistant strains of Salmonellae all over the world. Multiresistance ranges between 5% to 86%. In a recent study in Pakistan multidrug resistance in Salmonellae has increased to over 39%. Hence alternative therapy is needed. Fluroquinolones are an effective alternative requiring a shorter course of treatment than conventional antimicrobial agents. Lomefloxacin because of its longer half life and convenient BD dose was used in a multicentre study to treat cases of typhoid group of fevers including cases due to multiresistant isolates. In order to overcome the challenge presented by the multiresistant salmoneallae, a dual purpose multicentre study was conducted in two stages. The first stage included a vitro study and the second in vivo study. Two hundred local salmonellae isolates were collected and their sensitivity and minimum inhibitory concentrations were determined by standard methods. Two hundred and fourteen patients clinically suspected of suffering from typhoid groups of fevers were given Lomefloxacin 200 mg. BD for 14 days. Forty percent of Salmonellae isolates were found to be multiresistant while only 2% were found to be resistant to Fluroqunilones. The mean MIC 90 was found to be 0.06 mg/L Lomefloxacin was found to be effective in over 97% cases for treating typhoid group fevers including the ones due to multiresistant isolates. The side effects were found to be minimal and transient.

Typhoid fevers: treatment with lomefloxacin. Publishing Authors By Initials

S Hafiz,F Habib,N Ahmad,I Haq,R Husain,

For similar bacterial infections and mycoses: bacterial infections: gram-negative bacterial infections: enterobacteriaceae infections: salmonella infections: typhoid fever research abstracts see: bacterial infections and mycoses: bacterial infections: gram-negative bacterial infections: enterobacteriaceae infections: salmonella infections: typhoid fever research

PUBMED ID PMID:

MEDLINE DATE:

Typhoid fevers: treatment with lomefloxacin. Journal Published:

PUBLICATION TYPE: Multicenter Study

Journal: JPMA. The Journal of the Pakistan Medical Associat

VOLUME: 48

Page Numbers: 168-70

Journal Abbreviation:

ISSN: 0030-9982

DAY: 12

MONTH: Jun

YEAR: 1998

Typhoid fevers: treatment with lomefloxacin. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7501162

Typhoid fevers: treatment with lomefloxacin. Keywords Mesh Terms:

KEYWORDS: Typhoid Fever

MESH TERMS: drug therapy

Chemical & Substance for Abstract: Typhoid fevers: treatment with lomefloxacin. Information

Substance Name: lomefloxacin

Registry Number: 98079-51-7

Grant and Affiliation Information for Typhoid fevers: treatment with lomefloxacin.

AFFILIATION: Mid East Medical Center, Clifton.

Country: PAKISTAN

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Pak Med Assoc

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Typhoid fevers: treatment with lomefloxacin Related Publications

• A critical evaluation of "the long case" in final MBBS examination.
• A new commercial strain of ergot adapted from a wild grass.
• An audit on hospital management of bronchial asthma.
• An epidemiologic study of cystitis among Muslim women attending an out-patients clinic in Karachi.
• Anxiety states in general practice.
• Assessment of hairline EEG as a screening tool for nonconvulsive status epilepticus: Response to Bubrick et al.
• Atherosclerotic Ischemic Nephropathy as a Cause of Chronic Kidney Disease: What can be done to Prevent End-stage Renal Disease?
• Battered child syndrome: what should a physician know about it?
• Comparison of mixed liquor filterability measured with bench and pilot-scale membrane bioreactors.
• Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality.
• Decolorization of direct dyes by salt fractionated turnip proteins enhanced in the presence of hydrogen peroxide and redox mediators.
• Dental services in Andhra Pradesh (India).
• Drug dependence in Mekran-Panjgur revisited.
• Enantiomorphic normalization of focally lesioned brains.
• Evalutation of Artemisia annua Strains for Higher Artemisinin Production*.
• Heterotopic glial tissue in tonsil: a case report.
• Measurement and theoretical characterization of electronic absorption spectrum of neutral chrysene (C18H12)and its positive ion in H3BO3 matrix.
• Mini-external fixation of two- and three-part proximal humerus fractures.
• Neural network models of tinnitus.
• Potential of plant polyphenol oxidases in the decolorization and removal of textile and non-textile dyes.
• Primary proliferative glomerulonephritis--a clinicomorphological analysis.
• Region-specific patterns of vascular remodelling occur early in atherosclerosis and without loss of smooth muscle cell markers.
• The Essential Oil of Perilla ocimoides: A Rich Source of Rosefuran.
• The assessment of physiotherapy in the rehabilitation of burns.
• The assessment of physiotherapy in the rehabilitation of burns.
• Typhoid fevers: treatment with lomefloxacin.
• Use of chemical coagulants to control fouling potential for wastewater membrane bioreactor processes.
• Using the key informant method to investigate childhood blindness related to vitamin A deficiency disorder in six rural sub-districts in Bangladesh.
• Variation in Forskolin Content in the Roots of Coleus forskohlii.
• Vascular endothelial oxidative stress in alcohol-induced hypertension.